Immunohistochemical study of metaplastic carcinoma and central acellular carcinoma of the breast: Central acellular carcinoma is related to metaplastic carcinoma

Medical Molecular Morphology

Volumn 45, Issue 1, 2012, Pages 14-21

  Yamaguchi, Rin ^a   Tanaka, Maki ^c   Kondo, Keiko ^b   Yokoyama, Toshiro ^b   Maeda, Ichiro ^e   Tsuchiya, Shin Ichi ^f   Yamaguchi, Miki ^b,c   Takahashi, Ryuji ^c   Ogata, Yutaka ^b   Abe, Hideyuki ^d   Akiba, Jun ^a   Nakashima, Osamu ^a   Kage, Masayoshi ^d   Yano, Hirohisa ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KURUME UNIVERSITY MEDICAL CENTER   (Japan)

^c Social Insurance Kurume Daiichi Hospital   (Japan)

^d KURUME UNIVERSITY HOSPITAL   (Japan)

^e ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Basal like tumor; Breast; Central acellular carcinoma; Ep CAM; Metaplastic carcinoma; Myoepithelial differentiation; Triple negative

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CYTOKERATIN 14; CYTOKERATIN 5; CYTOKERATIN 6; CYTOKERATIN 8; CYTOKERATIN AE1; CYTOKERATIN AE3; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPITHELIAL CELL ADHESION MOLECULE; ESTROGEN RECEPTOR; INVOLUCRIN; PROGESTERONE RECEPTOR; PROTEIN P63; VIMENTIN;

ARTICLE; BREAST CANCER; CENTRAL ACELLULAR CARCINOMA; CLINICAL ARTICLE; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; INVASIVE CARCINOMA; MATRIX PRODUCING CARCINOMA; ONCOGENE C KIT; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPINDLE CELL CARCINOMA; SQUAMOUS CELL CARCINOMA;

BREAST NEOPLASMS; CARCINOMA; CARCINOMA, BASAL CELL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; METAPLASIA; TUMOR MARKERS, BIOLOGICAL;

EID: 84863392190     PISSN: 18601480     EISSN: 18601499     Source Type: Journal    
DOI: 10.1007/s00795-010-0536-x     Document Type: Article

References (37)

1. Rosen PP (2001) Rosen's breast pathology. In: Rosen PP (ed) Carcinoma with metaplasia, 2nd edn. Lippincott-Raven, Philadelphia, pp 425-453
2. Wargotz ES, Norris HJ (1989) Metaplastic carcinomas of the breast. I. Matrix-producing carcinoma. Hum Pathol 20:628-635 (Pubitemid 19185291)
3. Wargotz ES, Deos PH, Norris HJ (1989) Metaplastic carcinomas of the breast. II. Spindle cell carcinoma. Hum Pathol 20:732-740 (Pubitemid 19203633)
4. Wargotz ES, Norris HJ (1989) Metaplastic carcinomas of the breast. III. Carcinosarcoma. Cancer (Phila) 64:1490-1499
5. Wargotz ES, Norris HJ (1990) Metaplastic carcinomas of the breast. IV. Squamous cell carcinoma of ductal origin. Cancer (Phila) 65:272-276 (Pubitemid 20035352)
6. Wargotz ES, Norris HJ (1990) Metaplastic carcinomas of the breast: V. Metaplastic carcinoma with osteoclastic giant cells. Hum Pathol 21:1142-1150 (Pubitemid 20381997)
7. WHO classification of tumours (2003) In: Tavassoli FA, Devilli P (eds) Tumours of the breast and female genital organs. Pathology and genetics of tumours of the digestive system. World Health Organization classification of tumours. IARC Press, Lyon, pp 37-41
8. Yamaguchi R, Horii R, Maeda I, Suga S, Makita M, Iwase T, Oguchi M, Ito Y, Akiyama F (2010) Clinicopathologic study of 53 metaplastic breast carcinomas: their elements and prognostic implications. Hum Pathol 41:679-685
9. Tsuda H, Takarabe T, Hasegawa T, Murata T, Hirohashi S (1999) Myoepithelial differentiation in high-grade invasive ductal carcinomas with large central acellular zones. Hum Pathol 30:1134-1139 (Pubitemid 29480879)
10. Tsuda H, Takarabe T, Hasegawa F, Fukutomi T, Hirohashi S (2000) Large, central acellular zones indicating myoepithelial tumor differentiation in high-grade invasive ductal carcinomas as markers of predisposition to lung and brain metastases. Am J Surg Pathol 24:197-202 (Pubitemid 30078708)
11. Sasaki Y, Tsuda H, Ueda S, Asakawa H, Seki K, Murata T, Kuriki K, Tamai S, Matsubara O (2009) Histological differences between invasive ductal carcinoma with a large central acellular zone and matrix-producing carcinoma of the breast. Pathol Int 59:390-394
12. Yamaguchi R, Tanaka M, Yokoyama T, Nonaka Y, Kojima K, Terasaki H, Yamaguchi, M, Fukunaga M, Toh U, Nakashima O, Kage M, Yano H (2010) Clinicocytopathologic study of breast cancers with a ring-like appearance on ultrasonography and/or magnetic resonance imaging. Pathol Int 60:20-26
13. Yamaguchi R, Tanaka M, Mizushima Y, Hirai Y, Yamaguchi M, Hiroshi Terasaki H, Yokoyama T, Tsuchiya SI, Nakashima O, Yano H (2010) "High-grade" central acellular carcinoma and matrix-producing carcinoma of the breast: correlation between ultrasonographic findings and pathological features. Med Mol Morphol 44:151-157
14. Tsuda H, Sakamaki C, Fukutomi T, Hirohashi S (1997) Squamoid features and expression of involucrin in primary breast carcinoma associated with high histological grade, tumour cell necrosis and recurrence sites. Br J Cancer 75:1519-1524 (Pubitemid 27196876)
15. Rakha EA, Putti TC, Abd El-Rehim DM, Paish C, Green AR, Powe DG, Lee AH, Robertson JF, Ellis IO (2006) Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation. J Pathol 208:495-506 (Pubitemid 43329336)
16. Korsching E, Packeisen J, Liedtke C, Hungermann D, Wülfing P, van Diest PJ, Brandt B, Boecker W, Buerger H (2005) The origin of vimentin expression in invasive breast cancer: epithelial-mesenchymal transition, myoepithelial histogenesis or histogenesis from progenitor cells with bilinear differentiation potential? J Pathol 206:451-457 (Pubitemid 41025348)
17. Sarrio D, Rodriguez-Pinilla SM, Hardisson D, Cano A, Moreno-Bueno G, Palacios J (2008) Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype. Cancer Res 68:989-997 (Pubitemid 351272216)
18. Sørlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, van de Rijn M, Jeffrey SS, Thorsen T, Quist H, Matese JC, Brown PO, Botstein D, Eystein Lønning P, Børresen-Dale AL (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A 98:10869-10874
19. Nielsen TO, Hsu FD, Jensen K, Cheang M, Karaca G, Hu Z, Hernandez-Boussard T, Livasy C, Cowan D, Dressler L, Akslen LA, Ragaz J, Gown AM, Gilks CB, van de Rijn M, Perou CM (2004) Immunohistochemical and clinical characterization of the basallike subtype of invasive breast carcinoma. Clin Cancer Res 10:5367-5374 (Pubitemid 39100473)
20. Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, Conway K, Karaca G, Troester MA, Tse CK, Edmiston S, Deming SL, Geradts J, Cheang MC, Nielsen TO, Moorman PG, Earp HS, Millikan RC (2006) Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 295:2492-2502 (Pubitemid 43854964)
21. Tsuda H, Tani Y, Weisenberger J, Kitada S, Hasegawa T, Murata T, Tamai S, Hirohashi S, Matsubara O, Natori T (2005) Frequent KIT and epidermal growth factor receptor overexpressions in undifferentiated-type breast carcinomas with "stem-cell-like" features. Cancer Sci 96:333-339 (Pubitemid 41007467)
22. Carter MR, Hornick JL, Lester S, Fletcher CD (2006) Spindle cell (sarcomatoid) carcinoma of the breast: a clinicopathologic and immunohistochemical analysis of 29 cases. Am J Surg Pathol 30:300-309 (Pubitemid 43740161)
23. Kusafuka K, Muramatsu K, Kasami M, Kuriki K, Hirobe K, Hayashi I, Watanabe H, Hiraki Y, Shukunami C, Mochizuki T, Kameya T (2008) Cartilaginous features in matrix-producing carcinoma of the breast: four cases report with histochemical and immunohistochemical analysis of matrix molecules. Mod Pathol 21:1282-1292
24. Reis-Filho JS, Milanezi F, Steele D, Savage K, Simpson PT, Nesland JM, Pereira EM, Lakhani SR, Schmitt FC (2006) Metaplastic breast carcinomas are basal-like tumours. Histopathology (Oxf) 49:10-21 (Pubitemid 43972916)
25. Yamaguchi R, Furusawa H, Nakahara H, Inomata M, Namba K, Tanaka M, Ohkuma K, Tayama K, Fujii T, Yano H, Kage M, Kojiro M (2008) Clinicopathological study of invasive ductal carcinoma with large central acellular zone: special reference to magnetic resonance imaging findings. Pathol Int 58:26-30 (Pubitemid 350198304)
26. Wolff AC, Hammond ME, Schwartz JN, Hammond ME, Hayes DF, Dowsett M, Allred DC, Hagerty KL, Badve S, Fitzgibbons PL, Francis G, Goldstein NS, Hayes M, Hicks DG, Lester S, Love R, Mangu PB, McShane L, Miller K, Osborne CK, Paik S, Perlmutter J, Rhodes A, Sasano H, Schwartz JN, Sweep FC, Taube S, Torlakovic EE, Valenstein P, Viale G, Visscher D, Wheeler T, Williams RB, et al. (2007) American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol 25:118-145 (Pubitemid 350003059)
27. Tsuda H, Akiyama F, Kurosumi M, Sakamoto G, Watanabe T (1998) Establishment of histological criteria for high-risk node-negative breast carcinoma for a multi-institutional randomized clinical trial of adjuvant therapy. Japan National Surgical Adjuvant Study of Breast Cancer (NSAS-BC) Pathology Section. Jpn J Clin Oncol 28:486-491 (Pubitemid 128527326)
28. Bratthauer GL, Saenger JS, Strauss BL (2005) Antibodies targeting p63 react specifically in the cytoplasm of breast epithelial cells exhibiting secretory differentiation. Histopathology (Oxf) 47:611-616 (Pubitemid 41775184)
29. Xu Z, Wang W, Deng CX, Man YG (2009) Aberrant p63 and WT-1 expression in myoepithelial cells of pregnancy-associated breast cancer: implications for tumor aggressiveness and invasiveness. Int J Biol Sci 5:82-96
30. Yamaguchi R, Tanaka M, Kondo K, Yokoyama T, Kaneko Y, Yamaguchi M, Ogata Y, Yano H (2010) Characteristic morphology of invasive micropapillary carcinoma of the breast: an immunohistochemical analysis. Jpn J Clin Oncol 40:781-787
31. Narahashi T, Niki T, Wang T, Goto A, Matsubara D, Funata N, Fukayama M (2006) Cytoplasmic localization of p63 is associated with poor patient survival in lung adenocarcinoma. Histopathology (Oxf) 49:349-357 (Pubitemid 44401541)
32. Dhillon PK, Barry M, Stampfer MJ, Perner S, Fiorentino M, Fornari A, Ma J, Fleet J, Kurth T, Rubin MA, Mucci LA (2009) Aberrant cytoplasmic expression of p63 and prostate cancer mortality. Cancer Epidemiol Biomarkers Prev 18:595-600
33. Kurebayashi J, Moriya T, Ishida T, Hirakawa H, Kurosumi M, Akiyama F, Kinoshita T, Takei H, Takahashi K, Ikeda M, Nakashima K (2007) The prevalence of intrinsic subtypes and prognosis in breast cancer patients of different races. Breast 16:S72-S77
34. Sommers CL, Heckford SE, Skerker JM, Worland P, Torri JA, Thompson EW, Byers SW, Gelmann EP (1992) Loss of epithelial markers and acquisition of vimentin expression in adriamycin- and vinblastine-resistant human breast cancer cell lines. Cancer Res 52:5190-5197
35. Rouzier R, Perou CM, Symmans WF, Ibrahim N, Cristofanilli M, Anderson K, Hess KR, Stec J, Ayers M, Wagner P, Morandi P, Fan C, Rabiul I, Ross JS, Hortobagyi GN, Pusztai L (2005) Breast cancer molecular subtypes respond differently to preoperative chemotherapy. Clin Cancer Res 11:5678-5685 (Pubitemid 41170290)
36. Cleator S, Heller W, Coombes RC (2007) Triple-negative breast cancer: therapeutic options. Lancet Oncol 8:235-244 (Pubitemid 46291713)
37. Schmidt M, Hasenclever D, Schaeffer M, Boehm D, Cotarelo C, Steiner E, Lebrecht A, Siggelkow W, Weikel W, Schiffer-Petry I, Gebhard S, Pilch H, Gehrmann M, Lehr HA, Koelbl H, Hengstler JG, Schuler M (2008) Prognostic effect of epithelial cell adhesion molecule overexpression in untreated node-negative breast cancer. Clin Cancer Res 14:5849-5855